TABLE 2.
Healthcare resource utilization, direct medical costs, and clinical outcomes of patients with RSV positive.
| Nonhospitalized | Hospitalized | Overall | |
|---|---|---|---|
| n = 1043 | n = 1097 | n = 2122 | |
| Healthcare resource utilization | |||
| Patient who received emergency care, n (%) | 203 (19.5%) | 257 (23.8%) | 460 (21.7%) |
| Hospitalization length (days) | |||
| Mean ± SD | NA | 11 ± 17 | NA |
| Median (IQR) | NA | 6 (4, 10) | NA |
| Patient who received critical care, n (%) | NA | 257 (23.43%) | 257 (12.11%) |
| Length of stay in critical care unit (days) | |||
| Mean ± SD | NA | 24 ± 43 | NA |
| Median (IQR) | NA | 10 (5, 26) | NA |
| Direct medical costs, USD | |||
| Outpatient costs | |||
| Mean ± SD | 111 ± 532 | 64 ± 144 | 87 ± 387 |
| Median (IQR) | 63 (35, 103) | 39 (1, 83) | 53 (17, 94) |
| Emergency care costs | |||
| Mean ± SD | 104 ± 183 | 91 ± 131 | 97 ± 156 |
| Median (IQR) | 37 (26, 68) | 38 (8, 105) | 38 (17, 89) |
| Inpatient costs | |||
| Mean ± SD | NA | 2187 ± 6270 | NA |
| Median (IQR) | NA | 727 (432, 1356) | NA |
| Total hospitalization costs (outpatient + inpatient + emergency care costs) | |||
| Mean ± SD | 131 ± 541 | 2273 ± 6264 | 1220 ± 4608 |
| Median (IQR) | 66 (44, 113) | 814 (500, 1458) | 270 (67, 847) |
| Clinical outcome, n (%) | |||
| Patients with respiratory complications | 270 (25.9%) | 620 (57.5%) | 890 (41.9%) |
| Bronchiolitis | 62 (5.9%) | 99 (9.2%) | 161 (7.6%) |
| Pneumonia | 216 (20.7%) | 541 (50.1%) | 757 (35.7%) |
| Case fatality rate among RSV‐positive patients | 14 (1.3%) | 77 (7.1%) | 91 (4.3%) |
Note: 1 USD = 31.98 Thai Baht.
Abbreviations: NA, not available; RSV, respiratory syncytial virus; USD, US dollars.